Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue Suppl 1
1072 GI-108, a novel bispecific fusion protein augments anti-tumor immunity by alleviating immunosuppressive adenosine pathway in CD8+ T cells
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1072 GI-108, a novel bispecific fusion protein augments anti-tumor immunity by alleviating immunosuppressive adenosine pathway in CD8
+
T cells
Online download statistics by month:
Online download statistics by month: November 2023 to June 2025
Abstract
Full
Pdf
Nov 2023
186
0
16
Dec 2023
56
0
12
Jan 2024
33
0
2
Feb 2024
20
0
4
Mar 2024
20
0
4
Apr 2024
36
0
5
May 2024
42
0
4
Jun 2024
44
0
0
Jul 2024
38
0
7
Aug 2024
8
0
3
Sep 2024
38
0
2
Oct 2024
104
0
12
Nov 2024
86
0
12
Dec 2024
90
0
10
Jan 2025
76
0
13
Feb 2025
22
0
9
Mar 2025
0
0
14
Apr 2025
0
0
10
May 2025
0
0
5
Jun 2025
0
0
6
Total
899
0
150
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?